Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA, PTO Pulled Into Debate Over Patents And Drug Pricing
Feb 08 2022
•
By
Brenda Sandburg
US FDA and USPTO asked to analyze data on patents and drug pricing • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet